Please assess the completion status of the following clinical trial:

Trial Title: Multihance Versus Magnevist in Breast MRI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Provides written informed consent~* Female~* Age 18 years or older~* Suspicious or known breast lesion based on results from mammography or ultrasound~* Planned to undergo histological diagnosis of breast lesion by having a non surgical biopsy or breast surgery within 30 days after the MRI exam~Exclusion Criteria:~* Body weight \> 100 kg~* Pregnant or lactating~* Server or end-stage organ failure~* Moderate to severe renal impairment~* Undergoing radiotherapy or completed radiotherapy in the last 18 months~* Chemotherapy within 6 months of the 1st MRI exam

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).